Open access
179
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Results of a Time and Motion Survey Regarding Subcutaneous versus Intravenous Administration of Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma
Mary Slavcev1 Global Market Access, Janssen Global Services, Raritan, NJ, USACorrespondence[email protected]
, Allison Spinelli2 Global Medical Affairs, Janssen Global Services, Raritan, NJ, USA
, Elisabeth Absalon3 Real World and Late Phase, Syneos Health Clinical SARL, Paris, France
, Tara Masterson4 Medical Group Oncology, Janssen Research & Development, LLC, Spring House, PA, USA
https://orcid.org/0000-0001-8061-3576
Christoph Heuck4 Medical Group Oncology, Janssen Research & Development, LLC, Spring House, PA, USA
, Annette Lam1 Global Market Access, Janssen Global Services, Raritan, NJ, USA
& Erwin De Cock5 Real World and Late Phase, Syneos Health Clinical Spain SL, Madrid, Spain
show all
Pages 465-473
|
Published online: 08 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.